Medindia

X

Weakened Parasites Used to Make New Malaria Vaccine

by Kathy Jones on  September 10, 2011 at 6:14 PM Research News   - G J E 4
Using live but weakened malaria parasites as the basis of a vaccine represents a potentially encouraging anti-malaria strategy, scientists have found.

The parasite that causes malaria is transmitted to humans via the bite of an infected mosquito.
 Weakened Parasites Used to Make New Malaria Vaccine
Weakened Parasites Used to Make New Malaria Vaccine
Advertisement

After the bite occurs, infectious malaria parasites in the immature, sporozoite stage of their life cycle travel to the liver, where they multiply and then spread to the rest of the body through the bloodstream.

Advertisement
Researchers led by Stephen L. Hoffman, M.D., of Sanaria Inc., in Rockville, Md., created a candidate malaria vaccine against Plasmodium falciparum, the most deadly of the malaria parasites, by purifying these sporozoites and then weakening them with radiation.

In a clinical trial involving 80 healthy adult volunteers, the vaccine, called PfSPZ, was found to be safe and to induce a small immune response when given either intradermally (into the skin) or subcutaneously (under the skin).

Specifically, the results of the animal studies indicate that delivering PfSPZ intravenously, or directly into the bloodstream, may induce a significantly stronger immune response in the liver than subcutaneous or intradermal administration and thus may have a much greater effect in actually preventing malaria.

The findings were published online September 8 in Science Express.

Source: ANI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All